A contribution of ligand-activated RAGE to pregnancy-associated diseases such as preeclampsia (PE), gestational diabetes mellitus (GDM) and fetal growth restriction (FGR) is suspected, but data confirming this are lacking. This evidence concerns the gene AGER and gestational diabetes.